TD Mario MendoncaValuation On our 2022E and 2023E EPS, ECN is trading at 19.2x and 11.5x, respectively, compared with the five-year average (two-years forward) of 12.0x. ECN is also trading at approximately 4.7x Q2/22 BV. Justification of Target Price Our target price of C$5.00 (down from C$8.50) is based on a 15.0x P/E multiple applied to our one year forward EPS estimates (Q1/23E to Q4/23E). Our target P/E and BUY rating are supported by our view that through strategic capital allocation as well as the inherent value of MH financing (affordability) the business will continue to report solid growth, albeit at a slower pace than in 2022.